1.
Pediatr Dermatol
; 39(3): 486-487, 2022 May.
Article
in English
| MEDLINE
| ID: mdl-35797209
ABSTRACT
Drug-induced hypersensitivity syndrome (DIHS) is a type of severe cutaneous adverse reaction (SCAR). DIHS typically occurs 2-6 weeks after initiation of the offending medication. We report a case of DIHS in a pediatric patient undergoing treatment of metastatic melanoma with nivolumab and ipilimumab.
Subject(s)
Drug Hypersensitivity Syndrome , Eosinophilia , Melanoma , Child , Drug Hypersensitivity Syndrome/diagnosis , Drug Hypersensitivity Syndrome/etiology , Humans , Ipilimumab/adverse effects , Melanoma/drug therapy , Nivolumab/adverse effects
2.
3.
